Business Context and Reporting Period
Company: The Marcus Corporation (MCS)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended March 31, 2026 (Fiscal Q1 2026)
Business Segments: Movie Theatres and Hotels/Resorts
Fiscal Year Change: The Company transitioned to a calendar fiscal year effective December 27, 2024. Consequently, Q1 2026 (Jan 1 – Mar 31) contained five fewer operating days than Q1 2025 (Dec 27, 2024 – Mar 31).
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Total Revenues | $154.4 million | $148.8 million |
| Operating Loss | $(19.3) million | $(20.4) million |
| Net Loss | $(15.4) million | $(16.8) million |
| Net Loss Per Share (Diluted) | $(0.51) | $(0.54) |
| Adjusted EBITDA | $2.6 million | $(0.3) million |
| Cash and Cash Equivalents | $11.2 million | $23.4 million (Dec 31, 2025) |
| Long-Term Debt | $174.1 million | $159.0 million (Dec 31, 2025) |
| Net Leverage Ratio | 1.70x | 1.48x (Dec 31, 2025) |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 3.8% year-over-year, driven by growth in both segments despite the loss of five operating days.
- Theatres Segment: Revenues rose 6.4% to $92.9 million. Operating loss improved significantly by 55.3% to $(2.8) million. Adjusted EBITDA surged 117.1% to $8.0 million.
- Drivers: Admission revenues increased 9.5% due to a 1.9% rise in attendance and a 7.8% increase in average ticket price. The segment outperformed the U.S. box office industry by 4.8 percentage points.
- Hotels/Resorts Segment: Revenues were flat (0.1% increase) at $61.4 million. Operating loss widened 31.2% to $(7.9) million. Adjusted EBITDA turned negative at $(0.3) million.
- Drivers: RevPAR increased 13.7% to $92.60, outperforming the industry by 9.8 percentage points. However, results were negatively impacted by a weaker ski season at Grand Geneva Resort & Spa and the absence of a group buyout at a condo hotel that occurred in the prior year.
- Corporate Expenses: Increased $0.4 million due to higher stock compensation, incentive costs, and personnel inflation, partially offset by lower professional fees.
- Capital Expenditures: Decreased significantly to $6.6 million from $23.0 million in the prior year, reflecting reduced renovation activity.
Guidance, Outlook, and Risks
- Tax Outlook: Management anticipates an effective income tax rate for fiscal 2026 in the range of 32% to 34%, excluding potential legislative changes or one-time benefits.
- Hotel Outlook: Group room revenue bookings for fiscal 2026 are running approximately 5% ahead of the prior year pace. Banquet and catering pace is in-line with the prior year. Management expects business travel demand to soften in the near term while leisure demand remains stable in the upper upscale segment.
- Liquidity: The Company maintains a strong liquidity position with $194.3 million available under its $225 million revolving credit facility. Management believes this is sufficient to meet obligations for at least 12 months.
- Risk Factors: Key risks include adverse economic conditions, film availability and industry dynamics (e.g., strikes, tariffs), competitive conditions in lodging markets, and the capital-intensive nature of the business.
Investor Verification Checklist
- Operating Day Variance: Verify the impact of the five fewer operating days in Q1 2026 compared to Q1 2025 on revenue and operating loss calculations.
- Adjusted EBITDA Reconciliation: Review the non-GAAP reconciliation to understand the adjustments made to Net Loss, specifically the treatment of share-based compensation and non-recurring items.
- Debt Covenants: Confirm compliance with the Credit Agreement covenants, specifically the net leverage ratio (currently 1.70x vs. 3.50x limit) and interest coverage ratio.
- Hotel Segment Performance: Analyze the divergence between strong RevPAR growth and negative Adjusted EBITDA in the Hotels/Resorts segment to understand cost structure pressures.
- Share Repurchases: Note the reduction in share repurchase activity ($1.3 million in Q1 2026 vs. $7.1 million in Q1 2025) and the remaining authorization of approximately 4.4 million shares.